Status:
COMPLETED
Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Gastrointestinal Cancer
Neuroendocrine Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This single-blind, randomized controlled trial studies how well inhaled essential oils work for common quality of life concerns in patients who are undergoing cancer treatment such as chemotherapy, ta...
Detailed Description
PRIMARY OBJECTIVES: I. To determine if aromatherapy, specifically inhaled essential oil, is beneficial for side effects related to cancer treatments involving chemotherapy, targeted therapy, and/or i...
Eligibility Criteria
Inclusion
- Gastrointestinal cancers, neuroendocrine cancer, or melanoma or other skin cancers
- Receiving chemotherapy, targeted therapy, and/or immunotherapy
- Not naive to the treatment
- Must be able to read and write English
Exclusion
- Allergies to ragweed, chrysanthemum, chamomile, ginger, bergamot, citrus fruits, tree nuts, perfumes
- Asthma diagnosis
- Patients receiving only octreotide injections
- Patients receiving floxuridine (FUDR) via hepatic artery infusion (HAI) pump only
Key Trial Info
Start Date :
February 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2020
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT03858855
Start Date
February 18 2019
End Date
April 13 2020
Last Update
August 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210